With our partner in Europe, PLC continues to provide Regulatory support for the development of ARS-1. ARS Pharmaceuticals and Recordati Announce Exclusive License for the Rights in Europe and additional countries for NeffyTM (ARS-1; epinephrine nasal spray) Agreement will give access to millions at risk for severe allergic reaction to new pain-free delivery method for